Clinical evaluation and conformity assessment in EU MCQs With Answer

This set of MCQs on Clinical Evaluation and Conformity Assessment in the EU is designed for M.Pharm students aiming to master regulatory requirements for medical devices under the EU framework. The questions focus on clinical evaluation principles, clinical investigation, equivalence, post-market clinical follow-up (PMCF), the role of Notified Bodies, and key MDR provisions and annexes. Each question tests practical understanding of how clinical evidence is generated, assessed, documented (CER, SSCP), and used during conformity assessment for CE marking. Use these items to reinforce knowledge applied in regulatory submissions, risk-benefit evaluations, and post-market surveillance obligations under MDR 2017/745 and relevant guidance documents.

Q1. Which of the following best defines “clinical evaluation” under the EU MDR?

• A one-time literature search performed before placing a device on the market
• An ongoing, planned process to generate, collect, analyze and assess clinical data to verify conformity with safety and performance requirements
• A marketing assessment to demonstrate commercial viability in the EU market
• An internal quality control check limited to preclinical testing

Correct Answer: An ongoing, planned process to generate, collect, analyze and assess clinical data to verify conformity with safety and performance requirements

Q2. Which Annex of the EU MDR specifically addresses clinical evaluation and post-market clinical follow-up (PMCF)?

• Annex IX
• Annex X
• Annex XIV
• Annex XI

Correct Answer: Annex XIV

Q3. For which category of devices is a publicly available Summary of Safety and Clinical Performance (SSCP) explicitly required under the MDR?

• All class I devices
• All in vitro diagnostic devices
• Class III and implantable devices
• All class IIa devices

Correct Answer: Class III and implantable devices

Q4. Who normally performs the conformity assessment leading to CE marking for medium- and high-risk medical devices in the EU?

• The European Medicines Agency (EMA)
• The national ethics committee
• Notified Bodies designated by Member States
• The manufacturer alone without external assessment

Correct Answer: Notified Bodies designated by Member States

Q5. Which guidance document was widely used for clinical evaluation under the Medical Devices Directive (MDD) and is still referenced while transitioning to MDR guidance?

• MDCG 2020-1
• ICH-E6(R2)
• MEDDEV 2.7/1 rev 4
• ISO 9001

Correct Answer: MEDDEV 2.7/1 rev 4

Q6. What is required to demonstrate clinical “equivalence” to an existing device when relying on clinical data from that device?

• Only equivalent packaging and labeling
• Evidence of same intended purpose, and comparable technical, biological and clinical characteristics supported by robust justification
• Proof that both devices are sold in the same country
• Sharing of the same manufacturer marketing materials

Correct Answer: Evidence of same intended purpose, and comparable technical, biological and clinical characteristics supported by robust justification

Q7. What is the primary purpose of Post-Market Clinical Follow-Up (PMCF)?

• To replace pre-market clinical investigations permanently
• To proactively collect and evaluate clinical data on device performance and safety after placement on the market
• To assess manufacturing process efficiency
• To obtain marketing feedback on device aesthetics

Correct Answer: To proactively collect and evaluate clinical data on device performance and safety after placement on the market

Q8. When is a clinical investigation generally required under MDR?

• Only when the device is classified as class I sterile
• When available clinical evidence is insufficient to demonstrate compliance with safety and performance requirements
• For every device regardless of risk class
• Only for devices already on the market in other regions

Correct Answer: When available clinical evidence is insufficient to demonstrate compliance with safety and performance requirements

Q9. Which of the following elements must be included in a Clinical Evaluation Report (CER)?

• Only a bibliography of articles reviewed
• A detailed appraisal of clinical data sources, analysis of clinical performance and safety, and a conclusion on the device’s benefit-risk profile
• Only marketing and sales figures
• Only preclinical bench test results

Correct Answer: A detailed appraisal of clinical data sources, analysis of clinical performance and safety, and a conclusion on the device’s benefit-risk profile

Q10. Good Clinical Practice (GCP) standards are applicable to which of the following under EU device regulation?

• Manufacturing process validation only
• Clinical investigations of medical devices involving human subjects
• Device labeling grammar checks
• Not applicable to medical device studies

Correct Answer: Clinical investigations of medical devices involving human subjects

Q11. What is the main purpose of EUDAMED in the EU regulatory environment?

• To issue CE certificates to manufacturers
• To serve as the European database for medical devices, containing information on actors, UDI, vigilance, clinical investigations and certificates
• To replace national competent authorities
• To certify clinical investigators

Correct Answer: To serve as the European database for medical devices, containing information on actors, UDI, vigilance, clinical investigations and certificates

Q12. Which Annex of the MDR specifies conformity assessment based on a quality management system plus assessment of technical documentation?

• Annex IX
• Annex XII
• Annex XIV
• Annex XV

Correct Answer: Annex IX

Q13. Which of the following would generally make a claim of equivalence unacceptable when relying on another device’s clinical data?

• The devices share identical materials and design
• The devices have different intended clinical indications or treat different clinical conditions
• Both devices are manufactured in the EU
• The devices use the same regulatory classification

Correct Answer: The devices have different intended clinical indications or treat different clinical conditions

Q14. How often must the Clinical Evaluation Report (CER) be updated?

• Only once at initial CE marking and never again
• Continuously throughout the device lifecycle and whenever new clinical data or safety information becomes available
• Every ten years irrespective of new data
• Only when the manufacturer changes its address

Correct Answer: Continuously throughout the device lifecycle and whenever new clinical data or safety information becomes available

Q15. Which bodies typically review and approve a clinical investigation application in the EU?

• The national competent authority and the relevant ethics committee
• The European Commission only
• The local hospital procurement office
• The manufacturer’s marketing department

Correct Answer: The national competent authority and the relevant ethics committee

Q16. Which Annex of the MDR covers EU type-examination as a conformity assessment route?

• Annex XI
• Annex X
• Annex XIV
• Annex VIII

Correct Answer: Annex X

Q17. Which content is expected in the SSCP (Summary of Safety and Clinical Performance)?

• Only the device retail price and distributor list
• A non-technical summary including device description, intended purpose, summary of clinical evaluation, safety and performance outcomes and PMCF summary
• Confidential manufacturing formulas and supplier contracts
• Only pictograms for use instructions

Correct Answer: A non-technical summary including device description, intended purpose, summary of clinical evaluation, safety and performance outcomes and PMCF summary

Q18. What is the role of a Notified Body when assessing clinical evidence during conformity assessment?

• To provide clinical treatment to patients
• To independently evaluate the sufficiency and appropriateness of clinical data and the CER as part of the conformity assessment
• To approve marketing campaigns
• To perform clinical investigations on behalf of manufacturers

Correct Answer: To independently evaluate the sufficiency and appropriateness of clinical data and the CER as part of the conformity assessment

Q19. When relying on published clinical literature for clinical evidence, which of the following is essential?

• That the articles are written in any language without translation
• That the literature is relevant, of sufficient quality, deals with the same or equivalent device and addresses the intended clinical condition
• That the publications are older than 20 years
• That the literature originates only from the manufacturer’s country

Correct Answer: That the literature is relevant, of sufficient quality, deals with the same or equivalent device and addresses the intended clinical condition

Q20. Which regulation primarily governs clinical evaluation and conformity assessment of medical devices in the EU?

• Regulation (EU) 2017/745 (MDR)
• Directive 2001/83/EC
• The US Food, Drug, and Cosmetic Act
• Regulation on Veterinary Medicines

Correct Answer: Regulation (EU) 2017/745 (MDR)

Download